Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide

Louise Justesen Hesselbjerg, Heidi Sjoelund Pedersen, Mikael Bergholdt Asmussen, Karin Dam Petersen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    4 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide'. Sammen danner de et unikt fingeraftryk.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science